CIK 0001641281 · <br>Emerging growth company
Bolt Biotherapeutics, Inc.
Sign in to watch- Ticker
- BOLT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 472804636
- Phone
- 650-665-9295
- Business address
- 900 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
- Former names
- Bolt Therapeutics, Inc.
- Open-market buys, last 90 days
- $319,000
- in 1 filing
- Open-market sales, last 90 days
- $128,281
- in 3 filings
Net +$190,719. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-05 | Quinn William P. President, CEO and CFO | Purchase | +637 | $3.88 | $2K | 2,950 |
| 2026-01-28 | Quinn William P. President, CEO and CFO | Grant or award · Employee Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2026-01-28 | Yonehiro Grant Chief Operating Officer | Grant or award · Employee Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2026-01-28 | Nemec Sarah Senior VP, Finance and PAO | Grant or award · Employee Stock Option (Right to Buy) | +8,000 | 8,000 | ||
| 2025-12-12 | Dupont Jakob Director | Grant or award · Director Stock Option (Right to Buy) | +2,500 | 2,500 | ||
| 2025-12-12 | Dupont Jakob Director | Returned to the company · Director Stock Option (Right to Buy) | −2,500 | 0 | ||
| 2025-12-12 | Dupont Jakob Director | Grant or award · Director Stock Option (Right to Buy) | +849 | 849 | ||
| 2025-12-12 | Dupont Jakob Director | Returned to the company · Director Stock Option (Right to Buy) | −849 | 0 | ||
| 2025-12-12 | Dupont Jakob Director | Grant or award · Director Stock Option (Right to Buy) | +1,000 | 1,000 | ||
| 2025-12-12 | Dupont Jakob Director | Returned to the company · Director Stock Option (Right to Buy) | −1,000 | 0 | ||
| 2025-12-12 | Dupont Jakob Director | Grant or award · Director Stock Option (Right to Buy) | +1,100 | 1,100 | ||
| 2025-12-12 | Dupont Jakob Director | Returned to the company · Director Stock Option (Right to Buy) | −1,100 | 0 | ||
| 2025-12-12 | ONETTO NICOLE Director | Grant or award · Director Stock Option (Right to Buy) | +1,393 | 1,393 | ||
| 2025-12-12 | ONETTO NICOLE Director | Returned to the company · Director Stock Option (Right to Buy) | −1,393 | 0 | ||
| 2025-12-12 | ONETTO NICOLE Director | Grant or award · Director Stock Option (Right to Buy) | +1,107 | 1,107 | ||
| 2025-12-12 | ONETTO NICOLE Director | Returned to the company · Director Stock Option (Right to Buy) | −1,107 | 0 | ||
| 2025-12-12 | ONETTO NICOLE Director | Grant or award · Director Stock Option (Right to Buy) | +611 | 611 | ||
| 2025-12-12 | ONETTO NICOLE Director | Returned to the company · Director Stock Option (Right to Buy) | −611 | 0 | ||
| 2025-12-12 | ONETTO NICOLE Director | Grant or award · Director Stock Option (Right to Buy) | +1,250 | 1,250 | ||
| 2025-12-12 | ONETTO NICOLE Director | Returned to the company · Director Stock Option (Right to Buy) | −1,250 | 0 |
Page 2 of 17 · 337 trades